Search results
Please enter search term
Slaughter and May advised Westpac on the issue and listing on the Hong Kong Stock Exchange of AUD 2,760 million Class A Notes due 2050
Westpac on the issue and listing on the Hong Kong Stock Exchange of AUD 2,760 million Class A Notes due 2050
Slaughter and May advised the Central Bank of Egypt on a $3.8 billion syndicated repurchase transaction
Central Bank of Egypt on a $3.8 billion syndicated repurchase transaction
Slaughter and May advised Daily Mail and General Trust Plc on its proposed distributions to shareholders
Daily Mail and General Trust Plc on its proposed distributions to shareholders
Slaughter and May advised COSCO SHIPPING Ports in relation to its conditional agreement to subscribe for 60% of the shares in Terminales Portuarios Chancay S.A. for US$225 million
Slaughter and May advised COSCO SHIPPING Ports in relation to its conditional agreement to subscribe for 60% of the shares in Terminales Portuarios Chancay S.A. for US$225 million
Slaughter and May advised the Quartz group on a minority investment into the group by Inflexion
Quartz group on a minority investment into the group by Inflexion
Slaughter and May is advising Greencore Group plc on English aspects of its proposed return of capital of up to £509 million to shareholders
Greencore Group plc on English aspects of its proposed return of capital of up to £509 million to shareholders
Slaughter and May advised the Arsenal Football Club on the battery storage project with Pivot Power at Emirates Stadium
Arsenal Football Club on the battery storage project with Pivot Power at Emirates Stadium
Slaughter and May advised BHP Billiton on the disposal of interests in the Bruce and Keith North Sea oil and gas fields to Serica Energy
BHP Billiton on the disposal of interests in the Bruce and Keith North Sea oilfields to Serica Energy
Slaughter and May advised Dometic on its acquisition of Kampa
Dometic on its acquisition of Kampa
Slaughter and May is advising GlaxoSmithKline plc on the financing of its acquisition of TESARO, Inc.
GlaxoSmithKline plc on the financing of its acquisition of TESARO, Inc.